Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Clinical trial NCT06532656 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06532656
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2030-07-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.